NCT02798757View on ClinicalTrials.gov

Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Diabetes
Interventions
DRUG

Dapagliflozin

Urine samples will be collected for 1HNMR spectroscopies

Trial Locations (1)

45500

University of Ioannina, Ioannina

All Listed Sponsors
lead

University of Ioannina

OTHER

NCT02798757 - Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy | Biotech Hunter | Biotech Hunter